CLSA in The Bio Report: Biotech Investors Turn Their Eyes to Policy Matters
Oct. 16, 2015
As a curtain raiser to the 14th Annual BIO Investor Forum, CLSA Pres. & CEO Sara Radcliffe speaks with The BIO Report to discuss some of the key policy issues facing the biotechnology innovation ecosystem. This podcast covers a variety of public policy issues, including PDUFA VI, Trans-Pacific Partnership (TPP) and the 21st Century Cures Act.
The Bio Report is a weekly podcast focused on biotechnology at the intersection of business, policy, and science.
Radcliffe served on the advisory committee for the 14th Annual BIO Investors Forum. Learn more.